BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Equity Bancshares
EQBK
$1.06B
| $50.8K | ﹤0.01% |
1,666
-5,181
| -76% | -$159K |
|
3127
FRP Holdings
FRPH
$427M
| $50.7K | ﹤0.01% |
1,822
-4,278
| -70% | -$118K |
|
3128
Celldex Therapeutics
CLDX
$3.44B
| $50.5K | ﹤0.01% |
1,510
+1,189
| +370% | +$32.6K |
|
3129
Miller Industries
MLR
$634M
| $50K | ﹤0.01% |
1,268
-4,242
| -77% | -$181K |
|
3130
Krystal Biotech
KRYS
$9.86B
| $49.4K | ﹤0.01% |
727
-1,210
| -62% | -$84.5K |
|
3131
Farmers National Banc Corp
FMNB
$964M
| $49.4K | ﹤0.01% |
3,183
-8,895
| -74% | -$149K |
|
3132
MVB Financial
MVBF
$396M
| $49.2K | ﹤0.01% |
1,154
-3,141
| -73% | -$128K |
|
3133
Aviat Networks
AVNW
$284M
| $49.1K | ﹤0.01% |
+1,499
| New | +$52.2K |
|
|
REVG
3134
DELISTED
REV Group
REVG
| $49K | ﹤0.01% |
3,126
-8,915
| -74% | -$161K |
|
3135
KRONOS Worldwide
KRO
$960M
| $48.6K | ﹤0.01% |
3,397
-7,435
| -69% | -$121K |
|
3136
Lifecore Biomedical
LFCR
$182M
| $48.5K | ﹤0.01% |
4,313
-8,613
| -67% | -$99.3K |
|
3137
PUT
Archer Daniels Midland
ADM
$38.9B
| $48.5K | ﹤0.01% |
8
| – | – |
|
|
VOXX
3138
DELISTED
VOXX International Corporation Class A
VOXX
| $48.4K | ﹤0.01% |
3,455
-5,792
| -63% | -$93.9K |
|
3139
Citizens & Northern Corp
CZNC
$467M
| $48.4K | ﹤0.01% |
1,975
-4,334
| -69% | -$106K |
|
3140
Geron
GERN
$1.01B
| $48.4K | ﹤0.01% |
34,302
-86,273
| -72% | -$125K |
|
|
ALX
3141
Alexander's
ALX
$1.41B
| $48.2K | ﹤0.01% |
180
-437
| -71% | -$121K |
|
3142
Lifetime Brands
LCUT
$218M
| $48.2K | ﹤0.01% |
3,219
-3,631
| -53% | -$55.7K |
|
|
TEF
3143
DELISTED
Telefonica
TEF
| $47.5K | ﹤0.01% |
10,828
+10,190
| +1,597% | +$44.1K |
|
3144
Levi Strauss
LEVI
$8.6B
| $47.4K | ﹤0.01% |
1,711
+353
| +26% | +$9.7K |
|
3145
Purple Innovation
PRPL
$28.9M
| $47.3K | ﹤0.01% |
72
-216
| -75% | -$166K |
|
3146
Safe Bulkers
SB
$774M
| $47.2K | ﹤0.01% |
11,777
-13,158
| -53% | -$46.1K |
|
|
FRTA
3147
DELISTED
Forterra, Inc
FRTA
| $47.1K | ﹤0.01% |
2,005
-3,678
| -65% | -$86.2K |
|
3148
American Superconductor
AMSC
$1.55B
| $47K | ﹤0.01% |
2,704
-9,521
| -78% | -$152K |
|
3149
Mistras Group
MG
$563M
| $46.8K | ﹤0.01% |
4,757
-5,104
| -52% | -$55K |
|
3150
XBiotech
XBIT
$73.2M
| $46.7K | ﹤0.01% |
2,823
-4,131
| -59% | -$70.1K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.